Related Experiment Video

Updated: Jul 3, 2026

Assaying the Kinase Activity of LRRK2 in vitro
06:09

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

The biology and pathobiology of LRRK2: implications for Parkinson's disease

Darren J Moore1

  • 1Institute for Cell Engineering and Department of Neurology, Johns Hopkins University School of Medicine, Broadway Research Building, 733 North Broadway, Baltimore, MD 21205, USA. djmoore@jhmi.edu

Parkinsonism & Related Disorders
|July 8, 2008
PubMed

Insights

Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are a key cause of Parkinson's disease. Most mutations enhance LRRK2 kinase activity, leading to neuronal toxicity and disease.

Area of Science:

  • Neuroscience
  • Genetics
  • Biochemistry

Background:

  • Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are a significant cause of Parkinson's disease.
  • LRRK2 protein possesses both GTPase and kinase enzymatic domains, alongside protein-protein interaction domains.
  • LRRK2 functions as a GTPase-regulated protein kinase.

Purpose of the Study:

  • To review the biology and pathophysiology of LRRK2 in Parkinson's disease.
  • To discuss the impact of LRRK2 mutations on its enzymatic activity and cellular function.
  • To explore the role of LRRK2 in neuronal toxicity and disease pathogenesis.

Main Methods:

  • Literature review of LRRK2 genetics, biochemistry, and cell biology.
  • Analysis of pathogenic mutations and their effect on LRRK2 kinase activity.
  • Examination of LRRK2's role in cellular inclusions and neuronal toxicity.

Main Results:

  • The majority of pathogenic LRRK2 mutations result in enhanced kinase activity.
  • LRRK2 mutations are linked to the formation of cytoplasmic inclusions.
  • Disease-associated LRRK2 mutations induce neuronal toxicity in a kinase-dependent manner.

Conclusions:

  • LRRK2 is a central player in the pathogenesis of Parkinson's disease.
  • Enhanced LRRK2 kinase activity is a common mechanism underlying LRRK2-associated Parkinson's disease.
  • Understanding LRRK2's function and mutation effects is crucial for developing therapeutic strategies.

More Related Videos

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag08:55

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation12:49

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation

Published on: March 21, 2020

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.